Back to Search
Start Over
A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
- Source :
-
Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2013 Jun; Vol. 6 (3), pp. 538-45. Date of Electronic Publication: 2013 Apr 16. - Publication Year :
- 2013
-
Abstract
- Background: Current recommendations require a QRS duration of ≥120 ms as a condition for prescribing cardiac resynchronization therapy (CRT). This study was designed to test the hypothesis that patients with heart failure (HF) of ischemic origin, current indications for defibrillator implantation, and QRS <120 ms may benefit from CRT in the presence of marked mechanical dyssynchrony.<br />Methods and Results: Patients with intraventricular dyssynchrony on echocardiography were randomly assigned to CRT or dual-chamber defibrillator implantation (CRT defibrillator and dual-chamber implantable cardioverter-defibrillator arm, respectively). The primary end point was the HF clinical composite response, which scores patients as improved, unchanged, or worsened. The secondary end point was the cumulative survival from HF hospitalization and HF death. An additional secondary end point was the composite of HF hospitalization, HF death, and spontaneous ventricular fibrillation. Twenty-three of 56 patients with CRT defibrillator showed an improvement in their clinical composite response at 1 year, compared with 9 of 55 patients with dual-chamber implantable cardioverter-defibrillator (41% versus 16%; P=0.004). After a median follow-up of 16 months, the CRT defibrillator arm showed a nonsignificant higher survival from HF hospitalization and HF death (P=0.077), and a significantly higher survival from the combined end point of HF hospitalization, HF death, and spontaneous ventricular fibrillation (P=0.028).<br />Conclusions: In this comparison of CRT defibrillator and dual-chamber implantable cardioverter-defibrillator, CRT improved clinical status in some patients with ischemic cardiomyopathy, mild-to-moderate symptoms, narrow QRS duration, and mechanical dyssynchrony on echocardiography.<br />Clinical Trial Registration: URL: http://clinicaltrials.gov. Unique identifier: NCT01577446.
- Subjects :
- Cardiac Resynchronization Therapy methods
Cardiomyopathies diagnosis
Cardiomyopathies mortality
Echocardiography, Doppler
Electrocardiography methods
Female
Follow-Up Studies
Heart Failure diagnosis
Heart Failure mortality
Humans
Kaplan-Meier Estimate
Male
Myocardial Ischemia diagnostic imaging
Myocardial Ischemia mortality
Myocardial Ischemia therapy
Prospective Studies
Risk Assessment
Statistics, Nonparametric
Survival Rate
Tachycardia, Ventricular diagnosis
Treatment Outcome
Ventricular Dysfunction, Left diagnostic imaging
Ventricular Dysfunction, Left mortality
Ventricular Dysfunction, Left therapy
Cardiac Pacing, Artificial methods
Cardiomyopathies therapy
Defibrillators, Implantable
Heart Failure therapy
Tachycardia, Ventricular therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1941-3084
- Volume :
- 6
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Circulation. Arrhythmia and electrophysiology
- Publication Type :
- Academic Journal
- Accession number :
- 23592833
- Full Text :
- https://doi.org/10.1161/CIRCEP.113.000135